E-LIB Suche - Ergebnisse für: Burdett, Kirsten B

1

BIOM-39. P-ERK ASSOCIATION WITH OVERALL SURVIVAL IN RECURRE..:

Arrieta, Victor ; Duerinck, Johnny ; Burdett, Kirsten B...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii13-vii13 , 2022

Link: https://doi.org/10.1093/..

2

QOL-06. PREDICTING VENOUS THROMBOEMBOLISM IN PATIENTS WITH ..:

Burdett, Kirsten B ; Unruh, Dusten ; Drumm, Michael...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii241-vii242 , 2022

Link: https://doi.org/10.1093/..

3

CNSC-24. THE EPILEPTIC LANDSCAPE OF IDH MUTANT GLIOMAS:

Drumm, Michael ; Wang, Wenxia ; Burdett, Kirsten B...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii27-vii27 , 2022

Link: https://doi.org/10.1093/..

4

Publisher Correction: ERK1/2 phosphorylation predicts survi..:

Arrieta, Víctor A. ; Chen, Andrew X. ; Kane, J. Robert...
Nature Cancer. 3 (2022) 3 - p. 373-373 , 2022

Link: https://doi.org/10.1038/..

5

ERK1/2 phosphorylation predicts survival following anti-PD-..:

Arrieta, Víctor A. ; Chen, Andrew X. ; Kane, J. Robert...
Nature Cancer. 2 (2021) 12 - p. 1372-1386 , 2021

Link: https://doi.org/10.1038/..

6

Ribosomal protein S11 influences glioma response to TOP2 po..:

Awah, Chidiebere U. ; Chen, Li ; Bansal, Mukesh...
Oncogene. 39 (2020) 27 - p. 5068-5081 , 2020

Link: https://doi.org/10.1038/..

7

ERK1/2 phosphorylation predicts survival following anti-PD-..:

Arrieta, Víctor A ; Chen, Andrew X ; Kane, J Robert...
qt2v0702dq. , 2021

Link: https://escholarship.org..

8

Ribosomal protein S11 influences glioma response to TOP2 po..:

Awah, Chidiebere U ; Chen, Li ; Bansal, Mukesh...
qt0095v00v. , 2020

Link: https://escholarship.org..

9

Epidemiology and survival outcomes of HIV-associated cervic..:

Musa, Jonah ; Kocherginsky, Masha ; Magaji, Francis A....
Infectious Agents and Cancer. 18 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

10

Modeling Therapy-Driven Evolution of Glioblastoma with Pati..:

McCord, Matthew ; Bartom, Elizabeth ; Burdett, Kirsten...
Cancers. 14 (2022) 22 - p. 5494 , 2022

Link: https://doi.org/10.3390/..

11

Supplementary Figure S3 from ERK1/2 Phosphorylation Predict..:

Víctor A. Arrieta ; Johnny Duerinck ; Kirsten B. Burdett...
doi:10.1158/1078-0432.25011221.v1. , 2024

Link: https://doi.org/10.1158/..

12

Supplementary Table S1 from ERK1/2 Phosphorylation Predicts..:

Víctor A. Arrieta ; Johnny Duerinck ; Kirsten B. Burdett...
doi:10.1158/1078-0432.25011218.v1. , 2024

Link: https://doi.org/10.1158/..

13

Supplementary Figure S1 from ERK1/2 Phosphorylation Predict..:

Víctor A. Arrieta ; Johnny Duerinck ; Kirsten B. Burdett...
doi:10.1158/1078-0432.25011227.v1. , 2024

Link: https://doi.org/10.1158/..

14

Supplementary Figure S2 from ERK1/2 Phosphorylation Predict..:

Víctor A. Arrieta ; Johnny Duerinck ; Kirsten B. Burdett...
doi:10.1158/1078-0432.25011224.v1. , 2024

Link: https://doi.org/10.1158/..

15

A phase I/II study of intrathecal trastuzumab in human epid..:

Kumthekar, Priya U ; Avram, Michael J ; Lassman, Andrew B...
Neuro-Oncology. 25 (2022) 3 - p. 557-565 , 2022

Link: https://doi.org/10.1093/..